Westfield Capital Management’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-262,657
| Closed | -$76.1M | – | 246 |
|
|
2021
Q1 | $76.1M | Sell |
262,657
-30,969
| -11% | -$8.98M | 0.47% | 74 |
|
|
2020
Q4 | $73.4M | Buy |
293,626
+24,264
| +9% | +$6.06M | 0.44% | 82 |
|
|
2020
Q3 | $61M | Sell |
269,362
-32,248
| -11% | -$7.3M | 0.39% | 84 |
|
|
2020
Q2 | $52.6M | Buy |
301,610
+80,000
| +36% | +$13.9M | 0.36% | 94 |
|
|
2020
Q1 | $28M | Sell |
221,610
-5,046
| -2% | -$637K | 0.25% | 122 |
|
|
2019
Q4 | $34.6M | Buy |
226,656
+6,998
| +3% | +$1.07M | 0.25% | 129 |
|
|
2019
Q3 | $29.1M | Buy |
219,658
+37,479
| +21% | +$4.96M | 0.23% | 126 |
|
|
2019
Q2 | $25.9M | Sell |
182,179
-48,963
| -21% | -$6.95M | 0.19% | 153 |
|
|
2019
Q1 | $33.6M | Sell |
231,142
-3,535
| -2% | -$513K | 0.26% | 129 |
|
|
2018
Q4 | $26.6M | Buy |
+234,677
| New | +$26.6M | 0.23% | 133 |
|